Both hLF and bLF, when administered orally to mice with squamous cell carcinoma or basal-like breast cancer tumors, were found to enhance the effectiveness of conventional chemotherapy drugs, such as cisplatin and tamoxifen, and more effectively control the tumor growth [247,248]. This evidence concerns the gene HLF and neoplasm.